Amine Driouchi

Amine Driouchi has extensive work experience in the field of research and academia. Amine started their career at King's College London in 2009, where they served as a module adviser, e-learning adviser, and web content developer until January 2010. In June 2010, they became a visiting student researcher at The University of Edinburgh, where they contributed to various research projects until August 2010. Amine then joined Pharmidex in September 2010 as a Research Associate and worked until August 2011. After this, they joined the University of Chicago as a Postdoctoral Fellow in March 2019, where they conducted research until April 2021. Currently, Amine is working at Eikon Therapeutics, where they started as a Scientist II in April 2021 and was promoted to Senior Scientist in January 2023.

Amine Driouchi has an extensive educational background in various fields. From 2008 to 2012, they pursued a Bachelor of Science (BS) degree in Biochemistry with an Extramural Year at King's College London. In 2013, they enrolled in the University of Toronto, where they completed their Doctor of Philosophy (PhD) degree in Biochemistry/Biomedical Engineering in 2018. During this period, they also obtained a Postgraduate Certificate in Business Administration from Edinburgh Business School, Heriot-Watt University.

In 2018, Amine Driouch attended the University of Toronto - Rotman School of Management to specialize in Pharmaceutical Strategy. The following year, they further enhanced their knowledge and skills by obtaining a certificate in Entrepreneurship for Science and Medicine from The University of Chicago Booth School of Business.

Additionally, in September 2010, Amine Driouch obtained the Home Office Modules 1-4 (Animal License) certification from the UK Home Office.